Evidence map›Paper›PMID 37987952›Full record

ArticleJournal, genetic engineering & biotechnology2023

Adverse effect of Tamarindus indica and tamoxifen combination on redox balance and genotoxicity of breast cancer cell.

R A Guneidy, E R Zaki, G S A Abdel Karim, N S Saleh, A Shokeer

Open access · diamondAbstract read
In one paragraph

Article in Journal, genetic engineering & biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. The Health Benefits ofNutrients · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

R A GuneidyDepartment of Molecular Biology, Biotechnology Research Institute, National Research Centre, Cairo, Egypt. rasha_a_m_g@hotmail.com.ORCID http://orcid.org/0000-0002-3252-7654
E R ZakiDepartment of Molecular Biology, Biotechnology Research Institute, National Research Centre, Cairo, Egypt.
G S A Abdel KarimDepartment of Molecular Biology, Biotechnology Research Institute, National Research Centre, Cairo, Egypt.
N S SalehDepartment of Molecular Biology, Biotechnology Research Institute, National Research Centre, Cairo, Egypt.
A ShokeerDepartment of Molecular Biology, Biotechnology Research Institute, National Research Centre, Cairo, Egypt.
National Research Centre · EG

Funding

National research centre, Cairo, Egypt 121104
6 · The paper itself

Abstract

backgroundBreast cancer is the most significant threat to women worldwide. Most chemotherapeutic drugs cause cancer cell death and apoptosis by inducing oxidative stress and producing reactive oxygen species (ROS). Cancer cells have a higher rate of metabolic activity than normal cells and thus produce more ROS. Glutathione and its related enzymes are the most significant antioxidant defense mechanisms that protect cells from oxidative and chemotherapeutic impacts. The anticancer actions of phenolic compounds were greatly confirmed. Using phenolic compounds as drugs in combination with chemotherapy may improve health, improve treatment outcomes, and reduce dose and damage. The goal of the study was to treat breast cancer cell lines (MCF-7) with Tamarindus indica extract individually and in combination with the anticancer drug tamoxifen (TAM) to improve therapeutic efficacy.

resultsAfter 48 h of incubation at IC

conclusionCytotoxic and genotoxic effect of treatment with T. indica extract could be attributed to the dynamic interaction of glutathione cycle and antioxidant enzymes to combat oxidative stress, which can be considered as a positive therapeutic effect. On the other hand, the negative response of tamoxifen efficacy when co-treated with T. indica reversed tamoxifen's genotoxicity and enhanced survival.

Indexed as

Breast cancerCombination treatmentGenotoxicityGlutathione-related enzymesOxidative stressPlant cytotoxicityTamoxifen

Identifiers

PMID37987952
PMCPMC10663423
OpenAlexW4388865519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.